logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
X

Xiance Jin

Wenzhou Medical University First Affiliated Hospital
H指数:26
被引数:2,390

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrating deep learning and radiomics in the differentiation of major histological subtypes of invasive non-mucinous lung adenocarcinoma using positron emission tomography and computed tomography

整合深度学习和放射组学，利用正电子发射断层扫描和计算机断层扫描对主要组织学亚型的浸润性非粘液性肺腺癌进行鉴别。

TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2025-09-300
PRE
Wang, Dong; Liu, Huan; Cao, Zhuo; Huang, Weiqian; Fu, Wen; Shao, Li; Zhang, Ji; Su, Wanyu; Yu, Xianwen; Han, Ce; Ai, Yao; Xie, Congying; Jin, Xiance
Dosiomics-guided deep learning for radiation esophagitis prediction in lung cancer: optimal region of interest definition via multi-branch fusion auxiliary learning

剂量组学引导的深度学习用于肺癌放射性食管炎预测：通过多分支融合辅助学习进行感兴趣区域优化定义

Radiotherapy and Oncology
IF5.3
2025-09-060
PRE
Xianwen Yu; Yao Ai; Wanyu Su; Ziqing Xiang; Jianping Wu; Yiran Mu; Yifan Yang; Long Zhang; Wenliang Yu; Weihua Ni; Juebin Jin; Congying Xie; Xiance Jin
Deep learning dosiomics in grade 4 radiation-induced lymphopenia prediction in radiotherapy for esophageal cancer: a multi-center study

基于深度学习在食管癌放疗中预测4级放射性淋巴细胞减少症的多中心研究

Radiotherapy and Oncology
IF5.3
2025-06-210
PRE
Qiao Zheng; Xianwen Yu; Wenkai Pan; Yao Ai; Ziyang Liu; Tongbin Zhang; Ziqing Xiang; Xiyao Lei; Mingqi Zhu; Jianping Wu; Chengjian Xiao; Li Shao; Wenhao Guo; Sunjun Li; Junhao Ma; Yuxin Lou; Lijing Liu; Congying Xie; Xiance Jin
Combined deep learning and radiomics in pretreatment radiation esophagitis prediction for patients with esophageal cancer underwent volumetric modulated arc therapy

深度学习和放射组学联合预测容积调强电弧治疗食管癌患者的预处理放射性食管炎

RADIOTHERAPY AND ONCOLOGY
IF5.3
2024-10-013
PRE
Xie, Congying; Yu, Xianwen; Tan, Ninghang; Zhang, Jicheng; Su, Wanyu; Ni, Weihua; Li, Chenyu; Zhao, Zeshuo; Xiang, Ziqing; Shao, Li; Li, Heng; Wu, Jianping; Cao, Zhuo; Jin, Juebin; Jin, Xiance
Tibremciclib (BPI-16350) plus fulvestrant in patients with HR+/HER2-advanced breast cancer after progressing on endocrine therapy: A randomized, multicenter, double-blind, phase III study

Tibremciclib (BPI-16350) 联合氟维司群用于在接受内分泌治疗后进展的HR+/HER2-晚期乳腺癌患者：一项随机、多中心、双盲、III期研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Hu, X.; Tao, Z.; Wang, S.; Zhang, J.; Zheng, Q.; Wang, Y.; Cai, L.; Xu, H.; Xu, X.; Kong, X.; Ding, S.; Hao, C.; Wang, H.; Zong, H.; Jin, X.; Wang, X.; Li, Y.; Yang, X.; Ding, L.; Li, P.

研究方向

暂未获取到该数据
C
Congying Xie
H 指数:34论文数:289被引数:4,331
Y
Yao Ai
H 指数:15论文数:44被引数:566
J
Juebin Jin
H 指数:14论文数:38被引数:572
C
Ce Han
H 指数:13论文数:43被引数:485
H
Huafang Su
H 指数:20论文数:85被引数:1,761
J
Ji Zhang
H 指数:24论文数:171被引数:2,071
X
Xianwen Yu
H 指数:7论文数:38被引数:118
J
Jinling Yi
H 指数:11论文数:36被引数:346
Y
Yongqiang Zhou
H 指数:14论文数:45被引数:646
Z
Ziqing Xiang
H 指数:2论文数:20被引数:24